|
Market Cap (21-Jun) $15,071,113 (1,218th) |
Close (30-Jun) $6.60 |
Volume (30-Jun) 0 |
Shortsold (31-Aug) 59,797 (0.02%) (544th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -547.5 |
MDC released this announcement to the ASX on 16 November 2021, 10:30. The announcement is not marked as price sensitive, and is 25 page(s) in length and 2.86MB in size.
You can view all announcements from MDC and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from MDC | |
|---|---|
| Medlab Update to Shareholders | 7 June 2023, 10:22 |
| Response to ASX Query | 23 March 2023, 15:45 |
| Medlab Update to Shareholders | 21 March 2023, 10:39 |
| Medlab Presenting at Jefferies London Healthcare Conference | 16 November 2021, 10:30 |
| Further Information to Appendix 4C | 12 November 2021, 15:42 |
| Medlab Completes Nutraceuticals Divestment to PharmaCare | 11 November 2021, 8:33 |
| CEO Buys Medlab Shares - Appendix 3Y | 8 November 2021, 13:07 |
You must be logged in to post a reply.
Medlab Clinical 